Asthma 17q21 polymorphism and risk of COVID-19 in children: Correspondence
- PMID: 36052672
- PMCID: PMC9539228
- DOI: 10.1002/ppul.26120
Asthma 17q21 polymorphism and risk of COVID-19 in children: Correspondence
Abstract
This correspondence discusses on published article on asthma 17q21 polymorphism and risk of COVID-19 in children. The effect of other possible confounding factors are discussed.
Keywords: Asthma; COVID; children; polymorphism.
© 2022 Wiley Periodicals LLC.
Conflict of interest statement
None
Comment on
-
Asthma 17q21 polymorphism associates with decreased risk of COVID-19 in children.Pediatr Pulmonol. 2022 Nov;57(11):2855-2860. doi: 10.1002/ppul.26091. Epub 2022 Aug 17. Pediatr Pulmonol. 2022. PMID: 35932217 Free PMC article. No abstract available.
References
-
- Kouhpayeh HR, Tabasi F, Dehvari M, et al. Association between angiotensinogen (AGT), angiotensin‐converting enzyme (ACE) and angiotensin‐II receptor 1 (AGTR1) polymorphisms and COVID‐19 infection in the southeast of Iran: a preliminary case‐control study. Transl Med Commun. 2021;6(1):26. - PMC - PubMed
